AXSM
Axsome Therapeutics Inc
179.30$
-1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -92.7% | -42.4% | -71.3% | -34.5% | -17.8% | -22.1% | -35.7% | -21.6% | 0.6% | -9.5% | -10.8% | -15.1% | -9.2% | |
| 3.0% | 2.4% | 2.4% | 2.3% | 2.0% | 1.7% | 1.4% | 1.1% | 1.4% | 1.2% | 1.2% | 0.5% | 1.0% | |
| 25.7% | 26.4% | 26.9% | 24.5% | 20.7% | 18.5% | 19.2% | 16.4% | 13.5% | 11.6% | 12.3% | 12.4% | 12.4% | |
| 26.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -15.5% | 4.8% | -9.1% | 26.2% | -15.3% | 10.8% | -8.4% | -9.6% | 5.1% | -3.5% | 8.9% | -5.1% | 1.0% | |
| 0.6% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.3% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | |
| -0.6% | 0.0% | -0.1% | -0.1% | -0.1% | 0.0% | -0.3% | 0.0% | 0.0% | 0.0% | -0.1% | -0.2% | -0.1% | |
| 2.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.6% | -0.4% | -2.2% | -1.5% | 2.8% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -0.3% | -0.3% | -0.3% | -1.7% | -0.4% | -0.3% | -0.4% | -0.6% | -0.4% | |
| 57.7% | 0.0% | -1.6% | 16.5% | 29.0% | 12.0% | 24.1% | 23.0% | 12.4% | 8.4% | 1.6% | 22.0% | 11.4% | |
| -35.6% | -42.5% | -73.0% | -18.1% | 11.2% | -10.1% | -11.9% | 1.4% | 13.0% | -1.2% | -9.3% | 6.8% | 2.2% | |
| -93.3% | -42.5% | -71.4% | -34.6% | -17.6% | -22.1% | -36.0% | -21.6% | 0.6% | -9.6% | -10.9% | -15.0% | -9.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.